发明公开
- 专利标题： FUSION PROTEIN COMPRISING AXL AND COMPOSITION FOR TREATING CANCER COMPRISING SAME
- 专利标题（中）： 与Axl融合蛋白组成的癌症治疗THAT
-
申请号： EP13836076申请日： 2013-09-06
-
公开(公告)号： EP2894169A4公开(公告)日： 2016-03-02
- 发明人: SEO JEONG-SUN , KIM YOUNG-TAE , JU YOUNG-SEOK , KIM EUN-HEE , KANG JIN-HYOUNG
- 申请人： MACROGEN INC , SNU R&DB FOUNDATION , CATHOLIC UNIV IND ACAD COOP
- 专利权人： MACROGEN INC,SNU R&DB FOUNDATION,CATHOLIC UNIV IND ACAD COOP
- 当前专利权人： MACROGEN INC,SNU R&DB FOUNDATION,CATHOLIC UNIV IND ACAD COOP
- 优先权： KR20120099616 2012-09-07
- 主分类号： C07K19/00
- IPC分类号： C07K19/00 ; A61P35/00 ; C12N15/62 ; C12Q1/68
摘要：
Provided is a fusion protein comprising AXL receptor tyrosine kinase (AXL protein) and MAP3K12 binding inhibitory protein 1 (MBIP protein), a composition for diagnosing a cancer comprising a substance interacting with the fusion protein, a method of providing information for diagnosing a cancer using the fusion protein, a composition for preventing and/or treating a cancer comprising an inhibitor against the fusion protein, and a method for screening an anticancer agent using the fusion protein.
信息查询
